Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Abacavir-induced Platelet Reactivity in HIV
NCT03316534Phase 2Completed
- Sponsor
- Azienda Ospedaliera di Perugia
- Start
- Jan 2017
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of aspirin in cardiovascular diseases (CVD), sponsored by Azienda Ospedaliera di Perugia. Started Jan 2017; status: completed.
02
Drugs
aspirin
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT03316534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03316534.